654 related articles for article (PubMed ID: 15009838)
1. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
2. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
[TBL] [Abstract][Full Text] [Related]
3. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
6. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.
Kee TY; Chapman JR; O'Connell PJ; Fung CL; Allen RD; Kable K; Vitalone MJ; Nankivell BJ
Transplantation; 2006 Jul; 82(1):36-42. PubMed ID: 16861939
[TBL] [Abstract][Full Text] [Related]
7. Impact of Banff borderline acute rejection among renal allograft recipients.
Matoza JR; Danguilan RA; Chicano S
Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
[TBL] [Abstract][Full Text] [Related]
8. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
Töz H; Sen S; Seziş M; Duman S; Ozkahya M; Ozbek S; Hoşcoşkun C; Atabay G; Ok E
Transplant Proc; 2004; 36(1):134-6. PubMed ID: 15013324
[TBL] [Abstract][Full Text] [Related]
10. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
[TBL] [Abstract][Full Text] [Related]
11. Patterns of chronic injury in pediatric renal allografts.
Dart AB; Schall A; Gibson IW; Blydt-Hansen TD; Birk PE
Transplantation; 2010 Feb; 89(3):334-40. PubMed ID: 20145525
[TBL] [Abstract][Full Text] [Related]
12. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation.
Mao Y; Chen J; Shou Z; Wu J; Wang H; He Q
Transpl Immunol; 2007 Apr; 17(3):211-4. PubMed ID: 17331849
[TBL] [Abstract][Full Text] [Related]
14. Do we have to treat subclinical rejections in early protocol renal allograft biopsies?
Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Lekovski Lj; Ivanovski N; Popov Z
Transplant Proc; 2007 Oct; 39(8):2550-3. PubMed ID: 17954170
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus in chronic allograft nephropathy in pediatric recipients.
Ibáñez JP; Monteverde ML; Diaz MA; Goldberg J; Turconi AF
Pediatr Transplant; 2007 Nov; 11(7):777-80. PubMed ID: 17910656
[TBL] [Abstract][Full Text] [Related]
16. Protocol biopsies after kidney transplantation.
Böhmig GA; Regele H; Hörl WH
Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
18. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies.
Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A
Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
Stallone G; Infante B; Schena A; Battaglia M; Ditonno P; Loverre A; Gesualdo L; Schena FP; Grandaliano G
J Am Soc Nephrol; 2005 Dec; 16(12):3755-62. PubMed ID: 16236802
[TBL] [Abstract][Full Text] [Related]
20. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
